The essential roles played by the immune system in the discrimination between self-versus non/altered-self and its integral role in promoting host defense against invading microbes and tumors have been extensively studied for many years. In these contexts, significant advances have been made in defining the molecular and cellular networks that orchestrate cell-cell communication to mediate host defense and pathogen expulsion. Notably, recent studies indicate that in addition to these classical immune functions, cells of the innate and adaptive immune system also sense complex tissue-and environment-derived signals, including those from the nervous system and the diet. In turn these responses regulate physiologic processes in multiple tissues throughout the body, including nervous system function, metabolic state, thermogenesis, and tissue repair. In this review we propose an integrated view of how the mammalian immune system senses and interacts with other complex organ systems to maintain tissue and whole-body homeostasis.
Throughout life, an organism encounters multiple perturbations and stresses that interrupt homeostasis. Changes in diet, infections, temperature fluctuations, emotional disturbances, exposure to toxins, and mechanical damage are encountered daily (see Figure 1 ). The body must sense and cope with these continuously occurring perturbations and return to homeostasis. During a breach resulting from a bacterial or viral infection, four important steps occur before the organism returns to homeostasis. First, the perturbation is sensed, for example, through pattern recognition receptors; second, signals are sent to relay the degree and nature of the insult, i.e., via cytokine production; and, third, an effector response aimed at returning the system to homeostasis is implemented, such as granzyme and perforin release, which eradicates infected cells or tumors. The fourth step is resolution, which can involve repairing the collateral damage caused by a homeostatic breach. In extreme cases, however, less essential pathways provide energy crucial to survival. Inflammation, which occurs in response to infectious agents, noxious chemicals, and mechanical damage, is considered a breach in homeostasis and often results in poor outcomes, including disease. Yet inflammation is also an essential part of the body's homeostatic fluctuations that maintain pathways crucial to life.
Immune cells, which mediate pro-and anti-inflammatory responses, are found throughout the body and are major producers of soluble molecules, cytokines, hormones, and neuropeptides. They are therefore well positioned and equipped to sense, process, and relay physiological signals beyond their canonical role in eradicating pathogens and tumors. Different inflammatory responses are necessary for the eradication of specific pathogens, for example, type 1 immune responses counter intracellular bacteria and viruses; type 2 inflammation is important for the expulsion of helminths; and type 3 responses eradicate extracellular bacteria and fungi.
The equilibrium between these inflammatory responses is molecularly regulated by opposing immune pathways. For example, intracellular bacterial infections induce type 1 inflammation but consequently inhibit type 2 and type 3 responses (Eberl, 2016) . In addition, neuronal-derived products, host physiological perturbations (e.g., cold exposure), tissue damage, and diet also regulate the equilibrium between type 1, type 2, and type 3 immune responses. Reciprocally, the relative levels of type 1, type 2, and type 3 cytokines affect the function and homeostasis of multiple organs (see Figure 2) .
Recent advances in our ability to isolate relatively low numbers of immune cells from tissue, next-generation sequencing, and multi-color flow cytometry have allowed researchers to elucidate unique functions of the immune system in regulating nonlymphoid organ function. Here, we will describe recent advances in our understanding of how cytokine balance in the innate and adaptive immune systems is regulated by non-pathogenic signals, such as environmental-and neuronal-derived signals, and in turn how this cytokine balance regulates multi-organ homeostasis. Specifically, we will focus on recent findings that demonstrate how immune-derived signals regulate the neuronal circuitry, adipose tissue, and muscle function independent of pathogen challenge. We propose that recent advances in immunology research provide compelling evidence that the immune system functions as a multi-organ rheostat or buffer that, in absence of infection, continually senses homeostatic perturbations and relays signals to these tissues, thereby maintaining organismal homeostasis (see Figure 1 ).
Neuronal Regulation of Immune Responses
The concept of neuronal regulation of inflammation has been appreciated for decades. Multiple pathways from the nervous system integrate signals within immune cells during homeostasis and disease to regulate immune cell development and the balance between type 1, type 2, and type 3 inflammation (VeigaFernandes and Freitas, 2017; Veiga-Fernandes and Pachnis, 2017 ) (see Figure 2) . Vagus nerve stimulation, for example, leads to suppression of the immune response, whereas depressed function results in unresolved inflammation (Andersson and Tracey, 2012) . Additionally, the nervous system and neurotropic factors regulate hematopoiesis and egress of hematopoietic cells from the bone marrow (Fonseca-Pereira et al., 2014; Katayama et al., 2006) . Much of the earlier data linking neuropeptides to the immune response, however, has relied on in vitro culture experiments with little mechanistic data. The birth of elegant imaging techniques and mouse models together with multi-parameter flow-cytometry and next-generation sequencing has allowed a new appreciation for the role of neurons in the regulation of the immune system, and, thus, this warrants revisiting (Margolis and Gershon, 2016; VeigaFernandes and Mucida, 2016; Veiga-Fernandes and Pachnis, 2017) . Type 2 Responses It was recently shown that neurons promote type 2 inflammation through the release of specific neuropeptides. For example, cholinergic neurons in the lung and small intestine produce neuromedin U (NMU), which potently activates type 2 innate lymphoid cells (ILC2s) to proliferate and produce the type 2 effector and tissue-repair cytokines interleukin-5 (IL-5), IL-13, and amphiregulin (Areg; Klose et al., 2017; Cardoso et al., 2017; Wallrapp et al., 2017) . NMU signals through the G-protein-coupled receptor NMUR1, which is highly expressed on ILC2s. NMUR1 expression is particularly specific to ILC2s, which are located in close proximity to NMU-producing cholinergic neurons in the small intestine (see Figure 3A) . Thus, strong evidence suggests that ILC2s and neurons are closely interacting. Whether synapses can be formed between neurons and ILC2s and precisely how NMU locally diffuses to regulate ILC2 function is unclear. Nevertheless, this finding demonstrates that the type 2 inflammatory response is activated by Several recent studies have uncovered the contribution of the immune system in the regulation of not just pathogen expulsion but also other complex physiological processes, including neuron function in the central nervous system (CNS) and peripheral tissue, regulation of adipose tissue, and maintenance of metabolic and muscle tissue homeostasis. Dysregulation of the immune system in these tissues results in alteration in homeostasis and disease, such as obesity and neurological disorders. ASD, austism spectrum disorder; FAP, fibroadipogenic precursor; IBS, irritable bowel syndrome; WAT, white adipose tissue. neuronal cues that are released during environmental and physiological stresses.
Vasoactive intestinal peptide (VIP) is a 28 amino-acid peptide that was originally identified as a vasodilator in the gastrointestinal tract but has since been recognized as a neuropeptide. VIP signals through the b family of G-protein-coupled receptors VIPR1 and VIPR2, which earlier studies have shown to be expressed on multiple immune cells and to induce an anti-inflammatory response (Delgado and Ganea, 2001; Gonzalez-Rey and Delgado, 2007) . ILC2s express VIPR2 and signaling through VIPR2 promotes IL-5 production from ILC2s in the lung and the gut (Nussbaum et al., 2013; Talbot et al., 2015) . In the gastrointestinal tract, VIP is released in response to feeding and acts on ILC2s to produce IL-5, increasing systemic eosinophil numbers in a circadian manner (Nussbaum et al., 2013) . It was therefore proposed that VIP links immune rhythmicity with feeding oscillations and nutrient uptake. This suggests that mucosal-associated immune cells can respond to metabolic cues and alter the cytokine bias toward type 2 inflammation.
Furthermore, the sympathetic nervous system plays an important role in suppressing type 2 immune responses from ILC2s in an effort to resolve potentially pathological inflammation after helminth infection (Moriyama et al., 2018 ) (see Figure 3A) . Norepinephrine (NE) is an important chemical messenger produced by the sympathetic nervous system that is released from adrenergic neurons and involved in the regulation of the ''fight-or-flight'' response. This recent study demonstrated that ILC2s express b2 adrenergic receptor (b2AR), a receptor for NE. Activation of b2AR signaling resulted in reduced IL-5 and IL-13 production from ILC2s, and, conversely, treatment with an antagonist enhanced ILC2 proliferation and cytokine production, resulting in increased worm clearance. These data together suggest a regulatory mechanism for ILC2s mediated by two separate neuronal pathways, the cholinergic and sympathetic, which can enhance and limit ILC2 activity respectively. These two neuronal circuits described most likely play an important role in juggling the intricate balance between protective and pathological type 2 inflammation. It will be interesting to understand how these nervous system-regulated type 2 inflammatory pathways behave at steady state and regulate other physiological processes.
Type 1 Inflammation
In addition to its newly described role in regulating ILC2 function, the effects of NE signaling and its receptors on the immune In the classically held view of the immune system, different types of pathogens can shift the equilibrium of the immune response for sufficient eradication of specific pathogens. For example, helminth infection promotes type 2 inflammation, whereas intracellular viral infection results in type 1 inflammation. However, other physiological stimuli can also skew the immune response toward type 1, type 2, or type 3 immunity. Cold exposure results in type 2 inflammation, whereas a diet rich in tryptophan results in production of AHR ligands and promotion of type 3 immunity. These changes in the immune response can then feed back to other non-immune tissues to regulate homeostasis and promote pathologies. Areg, amphregulin; AHR, aryl hydrocarbon receptor; cGRP, calcitonin gene-related peptide; EC, epithelial cells; FAP, fibroadipogenic precursor; NE, norepinephrine; NMU, neuromedin U; VIP, vasoactive intestinal peptide. response have been studied for over half a century, albeit with limited in vivo tools. Previous work has linked NE signaling to the activation of type 1 inflammation and the alternative activation of macrophages. b2AR is dynamically expressed on T and B lymphocytes (Kolmus et al., 2015; Padro and Sanders, 2014; Sanders, 2012) . More specifically, it is expressed on naive T cells and T helper 1 cells, but downregulated on T helper 2 cells, where receptor engagement could promote interferon gamma (IFNg) production in the presence of IL-12 (Sanders, 2012) . However, caution needs to be taken with these conclusions, as they are based solely on in vitro studies. More recently, b2AR was found to be highly expressed on muscularis-resident macrophages (MM) that are closely associated with tyrosine hydroxylase (TH)-expressing enteric neurons, and TH is the rateliming enzyme essential for NE synthesis (Gabanyi et al., 2016) . b2AR activation on MM could then promote the polarization of MM into anti-inflammatory M2 MM (see Figure 3) . Notably, it appeared that the source of NE was derived from extrinsic sympathetic innervation. Sympathetic nerves sense pathogens and tissue damage (Gabanyi et al., 2016) , and NE is also an important regulator of stress and thermogenesis (Nguyen et al., 2011) , so it is interesting to consider the triggers for NE release in other non-immune tissues and the outcome of immune function and subsequent effect on organ homeostasis.
Type 3 Inflammation
Nerves and glial cells in the gut and skin activate type 3 responses. The skin is densely innervated with capsaicin receptor TRPV-1-expressing sensory neurons, known as nociceptive neurons that also regulate local immune responses. Specialized dermal dendritic cells (DDCs) live in close contact with nociceptive nerves in the dermis, which promote IL-23 production from DDCs (Riol-Blanco et al., 2014) . These neurons are directly activated by Candida albicans to produce the calcitonin gene-related peptide (CGRP) (Kashem et al., 2015) . Furthermore, the receptor for CGRP, Calcrl is highly expressed on DDCs, and CGRP stimulates IL-23 from DCs (Kashem et al., 2015) . Although this circuit was discovered in the context of pathogen insult, CGRP is released in response to multiple non-pathogenic stimuli, where these molecules could continually regulate immune function.
In the gastrointestinal tract, a family of ligands called glial-cellderived neurotropic factors signal through the tyrosine kinase receptor RET. These molecules not only support the development and function of neurons but also drive hematopoiesis in the bone marrow and type 3 immune responses (Fonseca-Pereira et al., 2014) . RET is expressed primarily on neurons, kidney cells, and a population of lymphoid cells present in the gut during ontogeny, known as lymphoid tissue initiator cells (LT in ) (VeigaFernandes et al., 2007) . These cells regulate Peyer's patch formation, where RET signaling leads to the attraction of LT in to the site of Peyer's patch development. More recently, it was found that enteric glial cells that produced RET ligands were closely associated with RET-expressing type 3 innate lymphoid cells (ILC3). These glial cell derived RET ligands could then activate IL-22 production from ILC3s in the gastrointestinal tract and promote epithelial integrity (see Figure 3A ) (Ibiza et al., 2016) .
Immune Cells Regulate Neurons
Immune cells themselves also produce neuropeptides and factors that regulate neuronal function. For example, MM produce bone morphogenic protein 2 (BMP2) that signals to the enteric nervous system. BMP2 signaling stimulates neurons to produce colony-stimulating factor (CSF), which then promote MM proliferation and intestinal peristalsis (see Figure 3A ) (Muller et al., 2014) . Type 2 cytokines can also activate nerves. Nociceptive nerves in the lung express IL-5Ra and are activated by IL-5 production from ILC2 and Th2 to produce VIP (Talbot et al., 2015) . Further, type 2 cytokines stimulate neurons in the skin via the IL-4-IL-4Ra axis to promote chronic itch (Oetjen et al., 2017) . Immune cells can also produce neuron-derived factors, such as serotonin (5-HT), VIP, acetylcholine, and catecholamines, that act on adipocytes, neurons, and smooth muscle to regulate other aspects of tissue physiology (Delgado and Ganea, 2001; Nguyen et al., 2011; Nowak et al., 2012; Rosas-Ballina et al., 2011) . This reciprocal relationship between peripheral nerves and immune cells allows for a continual feedback loop, where alterations in the cytokine milieu feed back into other physiological systems such as metabolism (Nussbaum et al., 2013; Pirzgalska et al., 2017) , intestinal epithelial cell function (Ibiza et al., 2016) , intestinal peristalsis (Gabanyi et al., 2016; Muller et al., 2014) , and lung integrity (Klose et al., 2017; Talbot et al., 2015; Wallrapp et al., 2017) . It will be important to decipher precisely how these neurotransmitters, such as acetylcholine and VIP, produced by immune cells regulate tissue physiology and further precisely how cytokine receptors are able to regulate action potentials in neurons.
The nervous system is essential for immediately perceiving, integrating, and responding to environmental perturbations and can therefore very quickly educate the immune system in situations of rapid sensing. Neuron-derived soluble mediators regulate similar effector responses as canonical cytokine pathways, but different processes induce them and can thus act in a complimentary but redundant way. Redundancy is evident across the immune system. Multiple cytokines activate the same effector responses, for example, IL-25 and IL-33 both elicit IL-13 and IL-5. Additionally, multiple developmentally distinct immune cells have overlapping functions, such as ILC3 and Th17 cells, which are both producers of IL-22 and IL-17 (Klose and Artis, 2016; Rankin et al., 2015; Song et al., 2015) . This suggests that signals from neurons could also act as a complimentary mechanism whereby alternative signals not activated by canonical cytokine pathways can regulate immune cell function via neuronal signals.
Activation of enteric neurons and glial cells by microbiota and helminth products triggers neuropeptide and neurotropic factor release, which relays information about pathogen and microbiota composition to immune cells. For example, these signals regulate T regulatory cell (Treg) function and promote innate regulate the vagus nerve, which controls inflammation and sickness behavior. Abbreviations: 5-HT, 5-Hydroxytryptamine; AHR, Aryl Hydrocarbon Receptor; Areg, Amphiregulin; BMP2, Bone Morphogenetic Protein 2; b2AR, b2 Andrenergic Receptor 2; IDO, Indolamine 2,3-dioxygenase; M2, Type 2 Macrophages; NE, norepinephrine; NMU, Neuromedin U; NMUR1, Neuromedin U Receptor 1; RET, Rearranged during Transfection; SCFA, Short Chain Fatty Acids; VIP, Vasoactive Intestinal Peptide; VIPR2, Vasoactive Intestinal Peptide Receptor 2. type 3 and type 2 immune responses (Cardoso et al., 2017; Ibiza et al., 2016; Wallrapp et al., 2017; Yissachar et al., 2017) . Physiological processes from cold exposure, food consumption, and the circadian cycle all influence production of neuronal-derived molecules (Harmar et al., 2002 ) that can subsequently signal to the immune system (Gabanyi et al., 2016) .
Many questions are still unanswered in this developing field. For example, could neuropeptides also synergize with canonical cytokine signals to amplify or dampen immune responses when necessary? What is the spatiotemporal coordination of these pathways? For example, are neuropeptides released immediately after a perturbation or are they a continual homeostatic signal? Can immune cells form synapses with neurons? For these questions to be answered, development of more complex live-imaging techniques will be required as well as refinement of optogenetic techniques to uncover precise neurons that activate specific immunological pathways. We will need to track neuropeptide release from activated nerves while assessing the activity of adjacent immune cells over time. Neuro-immune pathways are evolutionarily ancient and have been observed in organisms as primitive as C. elegans, which suggests these pathways are important regulators of host homeostasis (Aballay, 2009) . A plausible scenario is that neurons provide another layer of information for the immune system to sense in order to maintain a cytokine milieu most conducive to sustaining homeostasis.
Immune Cells Regulate Neurophysiology and Behavior
Immune dysfunction and microbial dysbiosis are associated with neurological disorders and changes in behavior. The balance between the type 1, type 2, and type 3 cytokine milieu alters the homeostatic set point of the central nervous system (CNS), thereby affecting neuronal function and behavior (see Figures 1  and 2 ). Preserving homeostasis of the CNS and neurological function is important for organism survival because these pathways regulate behaviors, such as feeding, energy expenditure, mating, and protection from predators. Neuro-physiological homeostasis in the CNS results from the careful crosstalk between neurons and its supporting glial cells, and perturbations in these pathways lead to behavioral changes and disorders, such as autism spectrum disorder (ASD), dementia, and schizophrenia.
The best-characterized behavior regulated by the immune system is sickness behavior, exhibited by all mammals during infection. Sickness behavior presents with anorexia, reduced libido, lethargy, and social withdrawal, behavioral changes that are thought to occur to reduce the risk of spreading infection and allow the body to rest and recover. Pro-inflammatory cytokines produced in response to inflammation by the innate immune system, namely tumor necrosis factor alpha (TNF-a), IL-6, IL-1b, and IL-18 can act on neuronal circuits to cause sickness behaviors such as anorexia and cognitive impairment (Herz and Kipnis, 2016; Kipnis, 2016) . IL-1b, for example, stimulates the vagus nerve to induce fever (see Figure 3B) . Further, systemic immune challenge activates TNF-a production from CX3CR1 + monocytes, which impairs dendritic spine plasticity that is important for learning and memory (Garré et al., 2017) . Sickness behavior may also act to alter metabolism and allow the host to tolerate to pathogen infection by limiting catastrophic tissue damage caused by inflammation (Medzhitov et al., 2012) .
These sickness behaviors are so well conserved that pathogens have evolved to modulate such behaviors to enhance fitness. S. typhimurium, for example, inhibits anorexia by modulating IL-1b-mediated regulation of the vagus nerve to reduce virulence and promote transmissibility to other hosts (Rao et al., 2017) . Of note, anorexia is protective during bacterial sepsis but lethal for viral infection. These anorexic effects are mediated by glucose utilization within the host with little consequence on pathogen burden . During bacterial infection, the additional glucose blocks ketogenesis, which is needed to protect the nervous system from reactive oxygen species (ROS)-mediated damage. In the case of viral infection, viral inflammation activates IFN signaling, thus inducing endoplasmic reticulum (ER) stress and the unfolded protein response (UPR); loss of glucose utilization pathways further exacerbates ER stress, resulting in catastrophic tissue dysfunction and death. This is one example of how inflammation-induced behavior can have huge repercussions on organismal homeostasis and fitness.
The immune system also regulates the homeostatic functions of the CNS. Brain-resident immune cells, namely microglia and astrocytes, influence neuronal function. Besides their canonical macrophage functions, such as phagocytosis, antigen presentation, and cytokine production, the fate of microglia and neurons are intertwined (see Figure 3B ) (Nayak et al., 2014; Nimmerjahn et al., 2005) . Microglia produce factors that promote neuronal survival, but their phagocytic activity is also important for the pruning of synaptic clefts during development to remove unnecessary neuronal processes (Nayak et al., 2014; Nimmerjahn et al., 2005) . Therefore, dysregulation of microglia can lead to neurological disorders. For example, Hoxb8 deficiency specifically in the hematopoietic system was shown to potentiate an excessive grooming pathology reminiscent of obsessive compulsive disorder (Chen et al., 2010) . During Parkinson's disease, microglia are highly activated and produce pro-inflammatory cytokines that contribute to neurodegeneration reminiscent of this disease (Sampson et al., 2016) .
Although immune cells do not typically cross the blood-brain barrier and enter the CNS, the meninges surrounding the CNS experience constant immunosurveilance. The meninges contain diverse populations of innate and adaptive immune cells that produce cytokines capable of crossing into the CNS that are drained by an intricate network of functional lymphatic vessels surrounding the dural sinus of the meninges (Gadani et al., 2017; Louveau et al., 2015) . The balance between type 1, type 2, and type 3 cytokines in the brain directly affects neuronal function. Adaptive immune system-derived cytokines regulate neuronal pathways long after active infection initially alters cytokine balance. The type 1 cytokine IFNg, for example, regulates neural connectivity (Filiano et al., 2016) . It was shown that IFNg can signal through the receptor ifngr1, which is expressed on prefrontal cortex neurons and regulates sociability (see Figure 3B ). Interestingly, these IFNg-neuron interactions were specifically mediated by adaptive immune system derived IFNg. While SCID mice lacking an adaptive immune system had defects in sociability, transfer of T cells could rescue the phenotype, suggesting sociability behavior was T cellmediated.
The cytokine IL-17 also regulates neuronal function, as it signals through IL-17Ra expressed on neurons in the fetal brain. Increased IL-17 signaling here results in abnormal cortical development and ASD-like behavioral abnormalities in the offspring (see Figure 3B) (Choi et al., 2016; Kim et al., 2017) . Additionally, lack of IL-6 signaling in the mother can block inflammatory signals to the fetal brain during development and prevent maternally induced autism (MIA) in the offspring . As IL-6 promotes the differentiation of Th17 cells, this could be one of the mechanisms whereby IL-6 exacerbates MIA. In this context, the IL-17-CNS pathway can be directly influenced by the intestinal microbiota, whereby microbial communities regulate IL-17-producing gdT cells and Th17 cells. Subsequently, intestinally induced IL-17-producing cells then migrate to the CNS and directly affect the outcome of brain injuries, such as ischemic stroke (Benakis et al., 2016) , or cause behavioral abnormalities in the developing fetus (Kim et al., 2017) . The true breadth of how cytokine balance regulates neuro-physiological homeostasis in the CNS is unclear and a topic of active research; however, a lot of evidence suggests that immune-derived signals directly affect the function of neurons in the CNS.
Immune-Adipose Interactions Metabolic Homeostasis
Brown adipose tissue (BAT) is functionally, developmentally, and anatomically distinct from white adipose tissue (WAT) and is characterized by its expression of uncoupling protein 1 (UCP-1), which catabolizes lipids to produce heat (Cohen and Spiegelman, 2015; Wu et al., 2012) . In WAT, beige adipose tissue can emerge in response to physiological stimuli in a process known as ''beiging.'' Brown adipose tissue and beiging of white adipose tissue promote increased energy expenditure, together with lipolysis of WAT to release the stored excess lipids as an energy source (Cohen and Spiegelman, 2015) . Metabolic fitness can be defined by insulin sensitivity that is regulated by multiple factors. In addition to adipocytes, adipose tissue comprises multiple stromal and immune populations, including macrophages, eosinophils, T cells, and ILCs, that support and maintain the function and development of adipocytes. Each immune compartment within the adipose tissue environment acts on multiple cell types, including stromal cells and adipocytes, to support metabolic function. In response to the local environment, immune cells respond to signals from stromal cells and adipocytes, such as adipokines (i.e., leptin, resistin, and adiponectin) and cytokines, that signal information about metabolic fitness and nutrient availability within adipose tissue to the immune system.
The balance between type 1 and type 2 inflammation is an important factor regulating metabolic homeostasis and insulin sensitivity (see Figure 2) . M2 macrophages support the extracellular matrix, produce anti-inflammatory cytokines, and phagocytose cellular debris. Th2 cells, ILC2s, and eosinophils are part of a regulatory network where ILC2s and Th2 cells produce IL-5 to support the survival and proliferation of IL-4-producing eosinophils (see Figure 4A , left) (Brestoff et al., 2015; Lee et al., 2014; Qiu et al., 2014) . IL-4 then directs the development of adipocyte precursors into beige fat and promotes alternative activation of macrophages and the proliferation and survival of IL-33-producing stromal cells, which in turn activates more IL-5 from ILC2s to promote beiging (Brestoff et al., 2015; Qiu et al., 2014) . ILC2s also produce methionine-enkephalin peptide (MetENK), which directly acts on adipocytes to orchestrate beiging of WAT (Brestoff et al., 2015) . IL-33 promotes proliferation of ST2-expressing Tregs, which are thought to dampen detrimental inflammation that causes the inflammatory phenotype seen in obesity (Cipolletta et al., 2012; Vasanthakumar et al., 2015) . Interestingly, IL-33 also directly acts on adipocytes to promote beiging and thermogenesis thereby preventing obesity (Cipolletta et al., 2012; Odegaard et al., 2016) . Furthermore, specific deletion of IL-33-responsive adipose tissue-resident Tregs results in increased susceptibility to metabolic disorders. Recent findings suggest, however, that this protective role of Tregs is not mediated by the immune-suppressive cytokine IL-10 (Rajbhandari et al., 2018) . This study found that deletion of IL-10 resulted in protection against diet-induced obesity and increased thermogenesis. IL-10 was able to signal directly through IL-10Ra on adipocytes and repressed the transcription of thermogenic genes, such as UCP1.
After high-fat diet feeding or genetically induced obesity, immune dysregulation contributes to metabolic disorder and insulin resistance. Here, cells involved in the type 2 immune response and Tregs are reduced or suppressed. On the other hand, IL-12 production promotes the activation and proliferation of type 1 pro-inflammatory cells, including IFNg-producing NK T cells, ILC1s, and Th1 cells, which results in the polarization to pro-inflammatory macrophages and increased TNF-a and IL-6 production (see Figure 4A , right). This results in dysregulation of adipose tissue and glucose homeostasis (O'Sullivan et al., 2016) . Complementarily, calorie restriction skews the adipose tissue toward type 2 inflammation, which results in beiging of WAT, thus preventing obesity in an IL-4-dependent manner (Fabbiano et al., 2016) . The balance between type 1 and type 2 immune responses is integral to metabolic health, and other factors skewing this balance, such as infection, diet, and microbiota can also have downstream consequences on adiposity and metabolism. Exactly how different diets regulate immune function, which then feeds back to adipose tissue biology and vice versa is an exciting topic of research that will require the development of novel techniques that decipher how these metabolites are incorporated into immuno-metabolic pathways in adipose tissue.
Bioenergetics and Thermogenesis
Prolonged cold exposure is a physiological stress that stimulates beta-adrenergic signaling and the development of functional brown and beige fat to increase total thermogenic capacity. Beige and brown fat development is triggered by catecholamine release from the sympathetic nervous system and also involves factors from the innate type 2 immune system (see Figure 4A , left) (Brestoff et al., 2015; Lee et al., 2014; Nguyen et al., 2011; Qiu et al., 2014) . Exposure to cold induces skewing toward type 2 inflammation and alternative activation of MM into the M2 phenotype, which requires IL-4 signaling (Nguyen et al., 2011) . Alternatively activated macrophages (AAMacs) express tyrosine hydroxylase, the rate-limiting enzyme for catecholamine production, essential for lipolysis and induction of thermogenesis. Further studies have since shown that the critical sources of IL-4 during cold exposure are eosinophils, which are also required for the biogenesis of beige fat (Nguyen et al., 2011; Qiu et al., 2014) . In addition, the type 2 promoting cytokine, IL-33 is required for functional UCP1 expression and thermogenesis in adipose tissue after cold exposure, another immunomodulatory molecule capable of regulating metabolic homeostasis (Odegaard et al., 2016) . Interestingly, a recent study has challenged this currently held dogma and reported that + T cells, and tissue-resident ILC1s. This promotes the dysregulation of adipose tissue, the formation of crown-like structures, and insulin resistance. During caloric restriction and cold exposure, the activation of type 2 inflammation supports and maintains the function of adipocytes by producing cytokines and factors that signal to adipocytes to promote beiging, thermogenesis, and insulin sensitivity. (B) The balance between type 1 and type 2 inflammation is also important for the regeneration and repair of muscle tissue. During the early stages of an abrasion, activation of the type 1 pro-inflammatory milieu stimulates and supports proliferating satellite cells. As the initial activation of precursors is occurring, the immune response shifts toward a type 2 cytokine milieu. These cytokines and growth factors direct the differentiation and the regeneration of myofibers and resolve inflammation through the production of anti-inflammatory cytokines. Abbreviations: AAMac, alternatively activated macrophage; Areg, amphiregulin; DAMP, damage-associated molecular pattern; FAP, fibroadipogenic precursor; MetENK, met-enkephalin; NE, norepinephrine; SAMs, sympathetic neuron-associated macrophages.
catecholamine production from AAMacs was not sufficient to promote thermogenesis (Fischer et al., 2017) . However, different models used in these two studies could explain these differing results. Another study has suggested that BAT-resident macrophages could directly control sympathetic innervation via Mecp2 expression, thus indirectly controlling NE release from neurons . In addition, a population of macrophages residing next to sympathetic neurons, termed ''sympatheticneuron associated macrophages'' (SAMs), are able to sequester NE upon activation of the sympathetic nervous system. This uptake shifted macrophages into a more pro-inflammatory state and subsequently reduced browning of adipose tissue (Pirzgalska et al., 2017) . Data here suggest that macrophages have a dual role in regulation of metabolic fitness depending on the stimuli and their localization. In summary, the balance of inflammatory cytokines produced by immune cells in adipose tissue uncouples its role in removing pathogens from its ability to rapidly integrate multi-organ signals and regulate metabolic homeostasis and bioenergetics.
Diet-Mediated Regulation of Immune Homeostasis
Metabolic by-products of neighboring host cells and microbes and diet-derived nutrients are important regulators of the immune system and metabolic homeostasis (Shibata et al., 2017; Veldhoen and Veiga-Fernandes, 2015) . The nutrient and energy availability to immune cells in the microenvironment is a direct regulator of immune cell metabolism and function. These molecules can be used as signals to report on the energy status of the organism and direct cell behavior in response to nutritional abundance or deprivation (Macpherson et al., 2017) . Metabolites also provide information on microbial composition to the immune system without the need for direct immune cell contact with these organisms. The effect of the ''western diet'' on immune function and subsequently metabolic homeostasis, for example, is pronounced. The western diet contains high levels of long chain fatty acids that are typically pro-inflammatory and promote T cell differentiation toward a Th17 bias, whereas the Mediterranean diet uses more u3-fatty acids that are anti-inflammatory (Calder, 2015; Haghikia et al., 2015; Thorburn et al., 2014) . u3-fatty acids and medium-to-long chain fatty acids contribute to the beneficial effect of the Mediterranean diet and immune dysfunction during high-fat diet, respectively. Further, this high-fat diet-induced type 1 proinflammatory state can then act on adipose tissue to promote metabolic dysfunction.
Micronutrients also have profound effects on immune cell function. They can be utilized by the metabolic pathways of immune cells and via ligand-receptor interaction. The vitamin A metabolite retinoic acid for example, induces tolerance by promoting transforming growth factor b (TGF-b)-induced differentiation of naive T cells into Tregs and also promotes IL-22 production from ILC3s, while inhibiting IL-5 from ILC2s (see Figure 3A ) (Mielke et al., 2013; Mucida et al., 2007; Spencer et al., 2014; van de Pavert et al., 2014) . Retinoic acid availability to the developing fetus directly regulates lymphoid structure formation and the development of ILC3s (van de Pavert and Mebius, 2010; van de Pavert et al., 2014) . The essential amino acid tryptophan also dynamically regulates many facets of the immune response. Tryptophan is the substrate for serotonin biosynthesis, which has known effects on immune function (Arreola et al., 2015 ) (see Figure 3) . Tryptophan can also be metabolized along the kynurenine pathway that involves idoleamine-2,3-dioxygenase (IDO) and tryptophan-2,3 dioxygenase (TDO), resulting in kynurenic acid synthesis and other aryl hydrocarbon receptor (AHR) ligands (Kennedy et al., 2017) . Other sources of AHR ligands are phytochemicals found in cruciferous vegetables and indoles that are metabolic products of the microbiota. AHR ligands activate AHR, a ligand-dependent transcription factor that translocates into the nucleus on ligand engagement. AHR then regulates gene expression and promotes the differentiation and function of resident-memory T cells, Th17 cells, ILC3s, intestinal epithelial lymphocytes (IELs) and gd T cells by directly regulating RORgt and IL-22 expression (Li et al., 2011; Cervantes-Barragan et al., 2017; Kiss et al., 2011; Qiu et al., 2012; Quintana et al., 2008; Zaid et al., 2014) . The immunological effects of AHR ligands reach as far as the brain, where they act on astrocytes to promote type 1 interferon signaling (see Figure 3B ) (Rothhammer et al., 2016) . The balance of tryptophan metabolizing enzymes in these pathways determines availability of tryptophan for serotonin and the kynurenine pathways. The gut microbiota modulate the expression of Tph1, the rate-limiting enzyme for serotonin biosynthesis in enterochromaffin cells through production of short chain fatty acids (SCFA), therefore germ-free (GF) mice have increased circulating tryptophan (Yano et al., 2015) . Inflammation and glucocorticoids released from stress regulate the expression of IDO and TDO respectively (Kennedy et al., 2017) . Therefore, tryptophan metabolic pathways are an important factor in the microbiota-neuralimmune axis that further translates information on the nutritional, inflammatory, microbial, and emotional state of the organism to the immune system.
Microbial-derived metabolites also have immuno-modulatory effects. The most abundant microbial metabolites are the short chain fatty acids (SCFA) butyrate, propionate, and acetate, bacterial fermentation products of fiber. SCFAs are important mediators of host-microbiota crosstalk and regulate host cellular metabolism. They regulate a huge array of physiological processes, including adiposity, behavior, epithelial barrier integrity, and nutrient uptake, by signaling through their receptors or acting as Histone deacetylase (HDAC) inhibitors to regulate gene expression. In the immune system, for example, SCFAs induce the differentiation of regulatory T cells (Arpaia et al., 2013; Furusawa et al., 2013; Smith et al., 2013) . They directly act on Tregs (Smith et al., 2013) or induce HDAC inhibition in DCs, which reduces proinflammatory cytokine production and promotes Treg differentiation (see Figure 3A ) (Arpaia et al., 2013) . In the CNS, microglia have dysregulated morphology and diminished response to infection in the absence of microbiota, which appears to be directly mediated by lack of SCFAs (see Figure 3B ) (Erny et al., 2015) . SCFAs are important molecules connecting diet and microbiota with the immune response. Direct consequences of lack of SCFAs are increased inflammation and loss of tolerance, which has been demonstrated by exacerbation of airway hyperactivity in the absence of SCFAs (Thorburn et al., 2015; Trompette et al., 2014) . Microbes in the gut have the capacity to produce an entire array of micronutrients that can alter immune function and the balance between different inflammatory states that then feed back to the microbiota. In the context of malnutrition, for example, bacterial communities are altered in such a way that their ability to synthesize and metabolize essential nutrients for the host is compromised or lost, resulting in altered immune responses and metabolic disorders (Hibberd et al., 2017; Sonnenburg and Sonnenburg, 2014; Subramanian et al., 2014) . In this way, the immune system is again acting as a sensor for the environmental insults inflicted on the host.
Immune Regulation of Tissue Regeneration and Repair
The fourth and last stage before returning to homeostasis is resolution, which often involves repair of tissue damaged as a result of homeostatic perturbations. Infection, in particular helminth infection, leads to acute and severe tissue damage. Beyond killing invading organisms, the immune system must repair the collateral damage associated with these infections in order to maintain fitness of the organism (see Figure 1) . The ability of an organism to recover from inflammatory damages is directly related to the susceptibility of the affected organ to damage, its capacity to self-renew and repair, and the functional importance of the organ (Medzhitov et al., 2012) . Therefore, these repair processes are essential to organismal homeostasis and survival. After tissue damage, the initial response is met with a pro-inflammatory type 1 cytokine milieu; however, during the regeneration and repair process the immune system moves to a more anti-inflammatory type 2 cytokine milieu (see Figure 2) . The type 2 immune response has evolved to limit and repair tissue damage after destructive helminth infections. However, this process occurs not only after infection, but also after sterile damage to maintain tissue homeostasis. These repair processes are mediated by production of growth factors and cytokines from immune cells that signal to local tissue progenitors and stromal cells. Immune Cell-Derived Areg in Tissue Repair T cells, Tregs, ILC2s, basophils, and mast cells all produce the epidermal growth factor (EGF)-like molecule amphiregulin (Areg) after inflammation . Areg is the ligand for the epidermal growth factor receptor EGFR, where signaling induces differentiation and proliferation of its target cells such as the lung epithelia and therefore plays diverse roles in tissue repair of multiple organs. In the lung, for example, Areg derived from ILC2s and a subset of ST2-expressing Tregs is important for tissue repair after damage from influenza infection (Arpaia et al., 2015; Monticelli et al., 2011; Zaiss et al., 2015) . Interestingly, this tissue repair function is uncoupled from their respective roles in pathogen clearance and tolerance. Here, Areg production can be elicited by IL-33 and neuronal-derived NMU signaling in ILC2s and requires IL-33 and IL-18 signaling in Tregs independent of TCR activation (Arpaia et al., 2015; Cardoso et al., 2017; Monticelli et al., 2011) . During a model of dextran sulfate sodium (DSS)-induced colitis, IL-33 can also elicit Areg from ILC2s in the colon and promote tissue repair ; however, the contribution of Areg-producing ST2 + Tregs and other immune cells in this process is yet to be investigated. In addition, it was reported that Th2 cells also upregulate the ligand for Areg, EGFR after TCR stimulation (Minutti et al., 2017) . EGFR can then form a complex with the IL-33 receptor and license IL-33-induced IL-13 production from Th2 cells. Therefore, Areg also acts in an autocrine fashion to promote IL-33-elicited IL-13 from Th2 cells (Minutti et al., 2017) . Inflammatory mediators and alarmins such as IL-33 that also regulate type 2 inflammation are released in response to tissue damage (sterile or infectious) and promote tissue repair processes from immune cells particularly involved in the type 2 pathways (see Figure 2 ). These mechanisms are most probably occurring on a daily basis. Daily insults such as exercise continually cause microabrasions that the immune system must respond to in order to maintain tissue integrity and function. Immune-Mediated Control of Muscle Tissue Homeostasis Immune cells are a healthy, non-obtrusive component of multiple tissues including skeletal muscle. During sterile trauma, such as burns, freezing, toxin exposure, and mechanical damage, immune cells mediate a stereotypical inflammatory response that is essential for the proper regeneration and repair of muscle tissue. Dysregulated immune response in the muscle leads to poor repair or exacerbation of fibrosis and impaired muscle function (Tidball, 2017) . Immune cells instruct muscle regeneration by acting directly on myocyte precursor cells (MPC) and resident fibroadipogenic precursors (FAPs). The earliest stage of muscle injury is skewed toward type 1 inflammation typified by IFNg production and polarization of macrophages to the M1 phenotype where cellular debris is phagocytosed. At this stage, IFNg stimulates MPC proliferation, but not differentiation. Subsequently, early pro-inflammatory M1 macrophages switch to a tissue regenerative and repair M2 phenotype typified by type 2 cytokine production that supports myocyte differentiation and the growth stage of myogenesis. Type 2 signals from eosinophils also support the proliferation and activation of IL-33-producing FAPs that clear cellular debris and support muscle stem cell growth and differentiation (see Figure 4B) (Heredia et al., 2013; Kuswanto et al., 2016) . The production of IL-33 by FAPs can promote the expansion of ST2 + Tregs that modulate myeloid populations through IL-10 and directly act on satellite cells via production of Areg (Burzyn et al., 2013; Kuswanto et al., 2016) .
Besides skeletal muscle repair, immune cells interact with other types of muscle tissue throughout the body independent of the presence of pathogens. For example, a role for macrophages has even been described in controlling electrical properties of cardiomyocytes. Macrophages were found in high proportions in the atrioventricular (AV) node of cardiac tissue and reported to form junctions with cardiomyocytes via the gap-junction protein Cx43 (Hulsmans et al., 2017) . Macrophage-specific loss of Cx43 impaired AV node conduction. It is still unclear how muscle-immune interactions can regulate multi-organ metabolic effects, such as insulin resistance and exercise physiology, a plausible scenario considering the function of skeletal muscles as a metabolic organ. However, commensal E. coli, for example, are able to directly activate the inflammasome and sustain signaling of the insulin-like growth factor pathway to prevent muscle wasting after salmonella infection. This finding suggests a role for the immune system in regulating muscle function and metabolism in the setting of infection (Schieber et al., 2015) . Muscle tissue also releases a recently described family of soluble molecules termed myokines. Myokines play diverse roles in muscle function and host physiology (Whitham and Febbraio, 2016) , and it is plausible that these molecules interact with the immune system to control muscle function and physiology; but how they do it is a largely unexplored area. The role of the immune system in muscle tissue integrity highlights yet another function of the immune system independent of pathogen eradication.
Concluding Remarks
Complex organisms have co-evolved with viruses, microbes, and other environmental pressures, including differing climates, diets, and social structures. Multicellular organisms evolved to sense environmental challenges and thus developed specialized sensory organs, namely the nervous and immune systems, to detect and respond to these changes. Decades of immunology research have attempted to understand how the immune system can sense and destroy foreign bodies without harming the host it set out to protect. However, the sensory and regulatory functions of the immune system extend far beyond the self-versus non-self-paradigm. Dietary, metabolic, and damage cues also alter the equilibrium between pro-and anti-inflammatory responses, which in turn regulate various physiological functions. Type 2 inflammation is crucial to maintain metabolic homeostasis and thermogenesis, and a tip of this balance toward type 1 signaling results in obesity and insulin resistance. Furthermore, neuronal signals and dietaryderived molecules regulate the inflammatory state of the organism, and these signals can feedback on adipose tissue and neuro-physiological homeostasis. These feedback loops can operate in a closed, sterile circuit; however, pathogens and commensal organisms also feed into this circuit. For example, a pathogenic insult will alter cytokine balance, modifying the inflammatory set point in a given tissue and influence tissue function.
It is becoming increasingly understood that dysregulation of the immune system results in diseases originally considered to be independent of the immune system, such as obesity, neurodegenerative disorders, and cognitive dysfunction. The function of the immune system is far more complex than previously appreciated. It works to regulate organismal homeostasis by sensing environmental and physiological perturbations, adapting to these alterations and re-establishing equilibrium in the host. It functions as a buffer to keep daily stresses in check and to ensure damage does not become irreversible, destroy tissue, and upset whole-body homeostasis. In this context, it may be of particular importance to dissect such pathways in light of changes in modern diet and lifestyle. With the advent of technology, our lifestyle has changed completely over the past one hundred years. Our diet is overprocessed, rich in sugar and fat, and low in fiber; we have exposure to fewer and different pathogens; and our fast-paced society promotes high stress levels and changes in social behavior. Associated with this is an observed increase in the incidence of depression and obesity, complex conditions now linked with alterations in immune system function. It is still unclear how all these systems are interrelated and how the microbiota-immune axis can shape the function of multi-organ systems. A mechanistic understanding of the relationships between the immune system and organismal homeostasis will greatly advance the development of strategies to treat such physiological pathologies. The hope is to understand immune sensing pathways to design better, more holistic approaches, such as dietary or microbial interventions, to treat complex multi-organ disorders.
